Development of Crescentic Immunoglobulin A Nephritis and Multiple Autoantibodies in a Patient during Adalimumab Treatment for Rheumatoid Arthritis

Chin Med J (Engl). 2015 Sep 20;128(18):2555-6. doi: 10.4103/0366-6999.164992.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / adverse effects*
  • Adalimumab / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology*
  • Asian People
  • Autoantibodies / immunology*
  • Female
  • Humans
  • Immunoglobulin A / immunology*
  • Middle Aged
  • Nephritis / etiology*
  • Nephritis / immunology*

Substances

  • Antirheumatic Agents
  • Autoantibodies
  • Immunoglobulin A
  • Adalimumab